Nettsider med emneord «Cancer»

Researchers have identified a novel immunotherapy for acute myeloid leukemia (AML). Immune cells are programmed to recognize a mutation found in leukemia patients. The results provide hope for new and effective treatment for the most common form of leukemia in adults.

Professor Johanna Olweus has been selected for the final of the Cancer Grand Challenges as part of a global research team. If successful, the team hopes to contribute in giving cancer patients new therapies.

The torpedoes reside in specific cells of the innate immune system. These cells could be the next breakthrough in cancer treatment.

Professor Stein Kaasa and international partners are among the shortlisted candidates for the Cancer Grand Challenges awards.